Display options
Share it on

FEBS Open Bio. 2017 May 11;7(6):821-834. doi: 10.1002/2211-5463.12232. eCollection 2017 Jun.

MSK1 regulates transcriptional induction of Arc/Arg3.1 in response to neurotrophins.

FEBS open bio

Chris J Hunter, Judit Remenyi, Sonia A Correa, Lucia Privitera, Kathleen M S E Reyskens, Kirsty J Martin, Rachel Toth, Bruno G Frenguelli, J Simon C Arthur

Affiliations

  1. MRC Protein Phosphorylation Unit College of Life Sciences Sir James Black Centre University of Dundee UK.
  2. Wellcome Trust Centre for Gene Regulation and Expression Wellcome Trust Building College of Life Sciences University of Dundee UK.
  3. Bradford School of Pharmacy Faculty of Life Sciences University of Bradford UK.
  4. School of Life Sciences University of Warwick Coventry UK.
  5. Division of Cell Signalling and Immunology Wellcome Trust Building College of Life Sciences University of Dundee UK.

PMID: 28593137 PMCID: PMC5458472 DOI: 10.1002/2211-5463.12232

Abstract

The immediate early gene activity-regulated cytoskeletal protein (Arc)/Arg3.1 and the neurotrophin brain-derived neurotrophic factor (BDNF) play important roles in synaptic plasticity and learning and memory in the mammalian brain. However, the mechanisms by which BDNF regulates the expression of Arc/Arg3.1 are unclear. In this study, we show that BDNF acts via the ERK1/2 pathway to activate the nuclear kinase mitogen- and stress-activated protein kinase 1 (MSK1). MSK1 then induces Arc/Arg3.1 expression via the phosphorylation of histone H3 at the Arc/Arg3.1 promoter. MSK1 can also phosphorylate the transcription factor cyclic-AMP response element-binding protein (CREB) on Ser133. However, this is not required for BDNF-induced Arc.Arg3.1 transcription as a Ser133Ala knockin mutation had no effect on Arc/Arg3.1 induction. In parallel, ERK1/2 directly activates Arc/Arg3.1 mRNA transcription via at least one serum response element on the promoter, which bind a complex of the Serum Response Factor (SRF) and a Ternary Complex Factor (TCF).

Keywords: Arc/Arg3.1; BDNF; CREB; MSK1; NMDA; glutamate; histone H3; neurotrophins

References

  1. Annu Rev Pharmacol Toxicol. 2013;53:311-30 - PubMed
  2. Nat Rev Neurosci. 2004 Mar;5(3):173-83 - PubMed
  3. Nat Neurosci. 2005 Jun;8(6):759-67 - PubMed
  4. Biochem J. 2005 Apr 15;387(Pt 2):507-17 - PubMed
  5. Pain. 2016 Nov;157(11):2594-2604 - PubMed
  6. Neuron. 2002 Aug 15;35(4):605-23 - PubMed
  7. Epigenetics Chromatin. 2016 Nov 11;9:52 - PubMed
  8. J Neurochem. 2009 Mar;108(6):1323-35 - PubMed
  9. J Neurosci. 2010 May 26;30(21):7168-78 - PubMed
  10. Nat Neurosci. 2011 Mar;14(3):279-84 - PubMed
  11. J Immunol. 2013 Jan 15;190(2):565-77 - PubMed
  12. EMBO J. 2003 Jun 2;22(11):2788-97 - PubMed
  13. eNeuro. 2017 Feb 20;4(1):null - PubMed
  14. Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):816-21 - PubMed
  15. Biochem J. 2005 Sep 15;390(Pt 3):749-59 - PubMed
  16. eNeuro. 2015 Mar 14;2(1):null - PubMed
  17. J Biol Chem. 2012 Feb 17;287(8):5412-25 - PubMed
  18. Mol Brain. 2012 May 14;5:14 - PubMed
  19. Proc Natl Acad Sci U S A. 2001 Sep 11;98 (19):10936-41 - PubMed
  20. Gene. 2004 Jan 7;324:1-14 - PubMed
  21. Brain Struct Funct. 2014 Jan;219(1):415-30 - PubMed
  22. EMBO J. 1998 Aug 3;17(15):4426-41 - PubMed
  23. J Neurosci. 2009 Feb 25;29(8):2393-403 - PubMed
  24. J Neurosci. 2002 Mar 1;22(5):1532-40 - PubMed
  25. Trends Neurosci. 2010 May;33(5):230-40 - PubMed
  26. Annu Rev Biochem. 1999;68:821-61 - PubMed
  27. Sci Rep. 2017 Jan 25;7:41221 - PubMed
  28. Mol Cell Biol. 2002 Apr;22(8):2871-81 - PubMed
  29. Mol Cell Biol. 2005 Dec;25(23):10286-300 - PubMed
  30. PLoS One. 2013;8(3):e60086 - PubMed
  31. Genes Dev. 2015 Mar 1;29(5):513-25 - PubMed
  32. Nat Rev Mol Cell Biol. 2011 Mar;12(3):141-51 - PubMed
  33. Nat Rev Neurosci. 2009 Dec;10(12):850-60 - PubMed
  34. Front Biosci. 2008 May 01;13:5866-79 - PubMed
  35. Neuron. 2007 Jan 4;53(1):79-89 - PubMed
  36. Trends Neurosci. 2009 Aug;32(8):432-42 - PubMed
  37. Neuropharmacology. 2014 May;80:3-17 - PubMed
  38. Cell Commun Signal. 2016 Aug 31;14 (1):18 - PubMed
  39. Neuron. 2006 Nov 9;52(3):475-84 - PubMed
  40. J Neurosci. 2007 Nov 14;27(46):12732-42 - PubMed
  41. J Neurosci. 2001 Aug 1;21(15):5484-93 - PubMed
  42. Eur J Pharmacol. 2011 Jun 25;660(2-3):351-7 - PubMed
  43. Trends Cell Biol. 2006 Nov;16(11):588-96 - PubMed
  44. Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609 - PubMed
  45. Cold Spring Harb Perspect Biol. 2012 Jan 01;4(1):a005736 - PubMed
  46. J Neurosci. 2004 May 5;24(18):4324-32 - PubMed
  47. Eur J Neurosci. 2008 May;27(10):2701-13 - PubMed
  48. Biochem J. 2007 Mar 15;402(3):491-501 - PubMed
  49. Cell. 2004 Oct 1;119(1):61-74 - PubMed
  50. Learn Mem. 2012 Oct 17;19(11):550-60 - PubMed
  51. Cancer Res. 2004 Dec 15;64(24):9076-9 - PubMed
  52. J Biol Chem. 2015 Mar 13;290(11):6825-36 - PubMed
  53. Nat Neurosci. 2017 Mar;20(3):476-483 - PubMed
  54. J Neurosci. 2009 Feb 4;29(5):1525-37 - PubMed
  55. Neuropharmacology. 2012 Dec;63(7):1227-37 - PubMed
  56. Nucleic Acids Res. 2008 May;36(8):2594-607 - PubMed
  57. Genesis. 2009 Oct;47(10):688-96 - PubMed
  58. Mol Cell. 2016 Oct 20;64(2):347-361 - PubMed
  59. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):316-21 - PubMed
  60. Nat Rev Neurosci. 2003 Apr;4(4):299-309 - PubMed
  61. PLoS One. 2013;8(1):e53848 - PubMed
  62. Mol Cell. 2003 Apr;11(4):1101-8 - PubMed
  63. Biochem J. 2012 Jan 1;441(1):347-57 - PubMed
  64. J Neurosci. 2012 Sep 19;32(38):13039-51 - PubMed
  65. Biochem J. 2007 Dec 15;408(3):297-315 - PubMed
  66. J Neurochem. 2012 Dec;123(5):676-88 - PubMed
  67. Biochem J. 2014 Mar 15;458(3):469-79 - PubMed
  68. J Neurosci. 2005 Dec 7;25(49):11444-54 - PubMed

Publication Types